Company / CapEx per Share
Crinetics Pharmaceuticals, Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.06
FY2025
5-year range
$0.01 / $0.08
FY2021-FY2025
Trend
+45.7%
vs FY2024
Sector context
#72 of 192
Health Care
What the data says
At $0.06, Crinetics Pharmaceuticals, Inc.'s capex per share ranks #72 of 192 in the Health Care sector. CapEx per Share has fluctuated over the past 10 years, ranging from $0.01 in FY2021 to $12.63 in FY2019.
Based on SEC 10-K filings.
0.06 in FY2025 with a 5-year CAGR of +6.7%.
Declined from $0.08 to $0.06 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +25.2%
- 5-Year CAGR
- +6.7%
- 10-Year CAGR
- -
Sector benchmark
#72 of 192 in Health CareTop 37% of 192This company $0.06 Sector average $3.54
▼
-98.3% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 45.7% year-over-year.
- Ranks #72 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2019.
- Lowest capex per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.06 | +45.7% |
| FY2024 | $0.04 | -48.8% |
| FY2023 | $0.08 | +162.6% |
| FY2022 | $0.03 | +235.5% |
| FY2021 | $0.01 | -79.0% |
| FY2020 | $0.04 | -99.7% |
| FY2019 | $12.63 | +10204.3% |
| FY2018 | $0.12 | -44.7% |
| FY2017 | $0.22 | +18.0% |
| FY2016 | $0.19 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026